These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6137093)

  • 1. [Agranulocytosis in patients with ulcerative colitis treated with salazosulphapyridine].
    Søndergaard JO; Stage JG; Sprechler M
    Ugeskr Laeger; 1983 Jul; 145(29):2225-7. PubMed ID: 6137093
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfasalazine-induced agranulocytosis.
    Jacobson IM; Kelsey PB; Blyden GT; Demirjian ZN; Isselbacher KJ
    Am J Gastroenterol; 1985 Feb; 80(2):118-21. PubMed ID: 2857524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Granulocytopenia in treatment with salazopyrin].
    Kvarstein G; Hovdenak N
    Tidsskr Nor Laegeforen; 1988 Nov; 108(32):2982-3. PubMed ID: 2908084
    [No Abstract]   [Full Text] [Related]  

  • 4. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine].
    Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S
    Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salicylazosulfapyridine-induced agranulocytosis in a patient with ulcerative colitis, successfully treated with granulocyte colony-stimulating factor].
    Matsubayashi Y; Izumi Y; Mori Y; Itoh K; Morioka A; Tatsuta H; Hashimoto A; Kotera T; Itoh A; Jo I
    Nihon Shokakibyo Gakkai Zasshi; 1991 Jan; 88(1):87-90. PubMed ID: 1709218
    [No Abstract]   [Full Text] [Related]  

  • 6. [Side effects of salicylazosulfapyridine therapy].
    Miller B
    Dtsch Med Wochenschr; 1980 Nov; 105(46):1596-7. PubMed ID: 6108200
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis.
    Collins JR
    South Med J; 1968 Apr; 61(4):354-8. PubMed ID: 4384520
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of depression in the treatment of nonspecific ulcerative colitis with sulfasalazine].
    Rebrov VG; Lukomskiĭ MI
    Klin Med (Mosk); 1989 Aug; 67(8):106. PubMed ID: 2572723
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H; Munakata A; Yoshida Y
    J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic epidermal necrolysis, agranulocytosis and erythroid hypoplasia associated with sulphasalazine.
    Maddocks JL; Slater DN
    J R Soc Med; 1980 Aug; 73(8):587-8. PubMed ID: 6112274
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of sulphasalazine-induced agranulocytosis with granulocyte macrophage-colony stimulating factor.
    Roddie P; Dorrance H; Cook MK; Rainey JB
    Aliment Pharmacol Ther; 1995 Dec; 9(6):711-2. PubMed ID: 8824661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Axonal neuropathy and salazosulfapyridine: slow-acetylator phenotype].
    Blin O; Sangla I; Jouglard J; Cottin C; Pellissier JF; Serratrice G
    Rev Neurol (Paris); 1992; 148(2):154-6. PubMed ID: 1351312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Agranulocytosis in rheumatoid polyarthritis treated with sulfasalazine].
    Pointud P; Cauhape P; Favreau A
    Rev Rhum Mal Osteoartic; 1989 Jun; 56(7):573. PubMed ID: 2569228
    [No Abstract]   [Full Text] [Related]  

  • 14. Sulfasalazine-induced DRESS and severe agranulocytosis successfully treated by granulocyte colony-stimulating factor.
    Fathallah N; Slim R; Rached S; Hachfi W; Letaief A; Ben Salem C
    Int J Clin Pharm; 2015 Aug; 37(4):563-5. PubMed ID: 25854308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulphasalazine-induced lupus-like syndrome with cardiac tamponade in a patient with ulcerative colitis.
    Deboever G; Devogelaere R; Holvoet G
    Am J Gastroenterol; 1989 Jan; 84(1):85-6. PubMed ID: 2563191
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.
    Das KM; Eastwood MA; McManus JP; Sircus W
    N Engl J Med; 1973 Sep; 289(10):491-5. PubMed ID: 4146729
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of ulcerative colitis with mesalazine intolerance complicated with agranulocytosis and septic shock during salazosulfapyridine administration].
    Ikehata A; Honta S; Sekino Y; Masuo T; Eizuka K; Inomata N; Ono S
    Nihon Shokakibyo Gakkai Zasshi; 2023; 120(9):764-772. PubMed ID: 37690832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surface necroses of the skin following sulfasalazine therapy in ulcerative colitis].
    Krakamp B; Beinhoff U; Knöpfle G; Leidig P
    Med Klin (Munich); 1988 Sep; 83(18):611-2. PubMed ID: 2903432
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathological changes in lungs and liver after therapy of ulcerative colitis].
    Matek W; Rösch W; Becker V
    Fortschr Med; 1980 Apr; 98(13):491-6. PubMed ID: 6102956
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute ulcerative colitis--a rare complication of sulfasalazine therapy.
    Ruppin H; Domschke S
    Hepatogastroenterology; 1984 Aug; 31(4):192-3. PubMed ID: 6148297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.